Latest Intravenous immunoglobulin Stories

 New research from Jefferson Hospital for Neuroscience (JHN) may redefine how Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is diagnosed. Eduardo De Sousa, M.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and director of the Electrodiagnostic Neuromuscular Lab at JHN, led the study which looked at the number of demyelinating features that are needed to differentiate between CIDP, Amyotrophic lateral sclerosis (ALS, or Lou...

LAS VEGAS and TOWSON, Md., May 11 /PRNewswire-USNewswire/ -- Founder and president of the Immune Deficiency Foundation (IDF), Marcia Boyle, traveled to Las Vegas this weekend to recognize the Cerda family, Wright Custom Home and many other community volunteers, for their efforts in raising awareness of primary immunodeficiency diseases (PIDD). The family, home builders and volunteers were featured on the May 10 episode of ABC's "Extreme Makeover: Home Edition." The full episode can be...

The Cerdas are Active Volunteers for the Immune Deficiency Foundation LAS VEGAS and TOWSON, Md., May 5 /PRNewswire-USNewswire/ -- Devastated by medical bills and a mold-ridden home that threatened their lives, Terri Cerda and her two young daughters, all three of whom are diagnosed with Combined Immune Deficiency Disease (CIDD), will be featured on the May 10 episode of ABC's "Extreme Makeover: Home Edition." CIDD is one of the most severe types of the more than 150 different primary...

Patients with rare, chronic inflammatory demyelinating polyneuropathy (CIDP) depend on plasma donation ANNAPOLIS, Md., April 24 /PRNewswire/ -- Chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating, progressive neurological disorder that results in muscle weakness and fatigue and can severely impair motor skills. According to the GBS/CIDP Foundation International, CIDP affects two to seven individuals per 100,000 worldwide. The rare disease is treated with intravenous...

18 patient advocacy and health care professional groups join with Congressional sponsors Reps. Israel, Brady and Schwartz to announce new legislation; call for patient access to IVIG WASHINGTON, April 22 /PRNewswire-USNewswire/ -- Members of Congress and patient advocacy groups announced today the introduction of new legislation - H.R. 2002, Medicare Patient IVIG Access Act of 2009 - meant to remedy inadequate Medicare reimbursements that currently restrict patient access to Intravenous...

SWARTZ CREEK, Mich., Feb. 4 /PRNewswire/ -- Diplomat Specialty Pharmacy is pleased to announce two new "Navigator" initiatives (disease management programs). As of January 2009, DSP launched both a Hemophilia and IVIG Navigator Program. In addition, Scott Reed has joined Diplomat as National Sales Manager for both programs. Reed is a graduate of Indiana University and has over 18 years of pharmaceutical sales experience. Most recently Reed was a Hematology Account Executive with Bayer...

Scientists at UCSF have discovered an abnormality in a patient's immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection.The research identified antibodies from a woman's immune system that prevent infection-fighting T cells from moving through her blood stream and entering her body's organs to attack invaders such as bacteria or viruses. Findings appear in the current online...

Grifols welcomes Los Angeles Mayor Antonio Villaraigosa, Cal State LA President James Rosser, Councilman Hose Huizar, patient representatives and other dignitaries for the construction dedication ceremony of its new IVIG facility. LOS ANGELES, Jan. 13 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, Grifols welcomes Los Angeles Mayor Antonio Villaraigosa., Cal State LA President James Rosser, Councilman Jose Huizar and other elected...

Patients with this Pediatric Disease Depend on Plasma Donation ANNAPOLIS, Md., Jan. 6 /PRNewswire/ --Kawasaki disease is an uncommon illness that typically affects children between the ages of two and five and is a leading cause of acquired heart disease in children in the United States according to the American Heart Association (AHA). Kawasaki disease is treated with intravenous immune globulin (IVIG), a plasma-derived therapy that replaces vital missing antibodies in a person's plasma...

Implications for new tests and more personalized treatments for autoimmune diseasesMore drafts usually mean a better product and so it also seems to go with the human immune system. As B cells develop, genes rearrange to allow their antibodies to recognize different foreign invaders or pathogens. But sometimes antibodies are created that recognize and attack the body's own cells. These self-reactive antibodies, like early drafts of a manuscript, must be edited into safer versions. This...